Staphylococcus aureus-Related Diabetic Osteomyelitis: Medical or Surgical Management? A French and Spanish Retrospective Cohort

Int J Low Extrem Wounds. 2015 Sep;14(3):284-90. doi: 10.1177/1534734614559931. Epub 2014 Dec 16.

Abstract

Staphylococcus aureus is the main cause of diabetic foot osteomyelitis (DFO) and can be treated medically or by surgery. We investigated the outcome of consecutive patients with a diagnosis of S aureus DFO retrospectively in 4 hospitals according to the type of management, medical (including debridement at bedside) or surgical. The outcome was classified as either favorable or failure (relapse, impaired wound healing, or amputation). Seventy-four patients with S aureus DFO, including 26 with methicillin-resistant S aureus, were included with a mean duration of follow-up of 21 ± 1 months. As part of the initial treatment, 47% underwent bone surgery followed with a short course of antibiotic. Others were treated with antibiotic therapy alone with bedside debridement. The outcome was favorable for 84% of these patients, with similar rates in the surgical and medical groups (80% vs 87%, P > .05). Patients in the medical group were less frequently hospitalized (49% vs 94%, P < .001) and had a shorter length of hospital stay (17 ± 3 vs 50 ± 12 days, P = .004). Patients in the surgery group received a shorter course of antibiotic therapy (10 ± 2 vs 11 ± 1 weeks, P = .001) with fewer side effects (9% vs 33%, P = .01). The type of management was not associated with subsequent new episode of noncontiguous DFO, which developed in 32% of cases. In conclusion, except significant differences in duration of hospitalization and antibiotic therapy, medical and surgical management of S aureus DFO had similar outcomes with a cure rate >80%.

Keywords: Staphylococcus aureus; amputation; diabetic foot; osteomyelitis.

Publication types

  • Multicenter Study

MeSH terms

  • Aged
  • Amputation*
  • Anti-Bacterial Agents / therapeutic use*
  • Debridement*
  • Decision Making
  • Diabetic Foot / complications*
  • Diabetic Foot / epidemiology
  • Diabetic Foot / therapy
  • Female
  • France / epidemiology
  • Humans
  • Incidence
  • Male
  • Osteomyelitis / epidemiology
  • Osteomyelitis / etiology*
  • Osteomyelitis / therapy
  • Spain / epidemiology
  • Staphylococcal Infections / epidemiology
  • Staphylococcal Infections / etiology*
  • Staphylococcal Infections / therapy
  • Staphylococcus aureus / isolation & purification*
  • Survival Rate / trends
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents